header-image

Transfusion Technology Assessment

Introduction

The Transfusion Technology Assessment (TTA) group was established in 2003 with the mission to provide scientific evidence to support informed decision making by Sanquin management and national and international policymakers based on statistical and mathematical modelling. Since its conception, TTA has worked on a broad range of projects, ranging from (health) economic and risk assessments to logistic optimization, data modelling, expert elicitation, optimal treatment of patients, value of information assessment and the development of decision support tools. The TTA group produces scientific publications, but also proprietary reports for Sanquin Executive Board. In the past years, in the course of the PROTON and DTD studies, TTA has compiled an invaluable source of information on the blood transfusion chain (BTC) that is unique for the Netherlands and rare in the world. TTA group has been invited to share its expertise with organizations like World Health Organization (WHO), the European Medicines Agency (EMA), the Council of Europe (EDQM), the European Blood Alliance (EBA), the Alliance of Blood Operators (ABO), the European Center for Disease Prevention and Control (ECDC) and the International Society for Blood Transfusion (ISBT).

Medical needs

Funding

  • PPOC (internal funding in competition)
  • ZonMw (The Netherlands Organisation for Health Research and Development)
  • European Blood Alliance (EBA)
  • European Center for Disease Prevention and Control (ECDC)
  • World Health Organization (WHO)
  • Alliance of Blood Operators (ABO)

Our research